News

A side hustle, or a second job aside from your full-time employment, can be a great way to earn extra money. It could even be a stepping stone to starting a business of your own, if you're

TheRealReal (NASDAQ: REAL) is growing fast, but the stock is still down substantially since its IPO. Is the market missing the opportunity here?

In this episode of "Upgrade or Topgrade," recorded on

Stitch Fix (NASDAQ: SFIX) is slated to report its results for the first quarter of fiscal 2022 (which ended Oct. 30) after the market close on Tuesday, Dec. 7.

Shares of the online

There are hundreds of dividend-paying stocks in the S&P 500. They come in all shapes and sizes. Some pay out high dividend yields, while others have long histories of steadily increasing their

The market will crash again. That is inevitable. The only real question is when will it happen?

Let's be clear: there are lots of reasons to believe the market could crash soon. Skyrocketing

There's no end in sight yet for BJ's Wholesale Club's (NYSE: BJ) growth spike. In an earnings report on Thursday, the warehouse retailer announced accelerating expansion trends that kept it near the

Rivian (NASDAQ: RIVN) hit the public markets last week. A company with only a few dozen vehicle sales and a market cap over $100 billion seems to have broken the imagination of some investors. But

ThredUp's (NASDAQ: TDUP) Clean Out Kits help distinguish the company from other secondhand sellers, giving individual sellers an easy way to ship to the company. With some technology advances, the

At first glance, it would appear as though CVS (NYSE: CVS) is having a pretty good year. The pharmacy chain's stock price is up roughly 41% from a year ago, and recently, it enjoyed

The pharmaceutical industry appears poised for a record-breaking level of merger and acquisition (M&A) activity in 2022. Four emerging trends back up this assertion.

First, Pfizer (NYSE: PFE) and

Kohl's (NYSE: KSS) served up another big earnings beat on Thursday. While the company has lagged many of its peers on revenue growth this year, it continued a streak of impressive margin expansion.

Bilibili's (NASDAQ: BILI) stock plunged 17% on Nov. 18 after the Chinese tech company posted its third-quarter earnings.

Its revenue rose 61% year over year to 5.21 billion yuan ($808 million)

Comparing Rivian Automotive (NASDAQ: RIVN) to Tesla (NASDAQ: TSLA) or Lucid Group (NASDAQ: LCID) is one thing. But staging a side-by-side of Rivian to a traditional automaker like Ford (NYSE: F) has

Poshmark (NASDAQ: POSH) has struggled since its IPO, with the stock down roughly 80% since its debut earlier this year. Shares have tumbled as the pandemic tailwinds have faded, but is there hope

When bank savings accounts are bragging about 0.4% interest rates and 10-year Treasury bonds are yielding 1.6%, it can be hard to figure out how best to grow your money. The answer for most of is

BioNTech (NASDAQ: BNTX) announced its third-quarter results on Nov. 9. In this Motley Fool Live video recorded on Nov. 10, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss

Zillow Group (NASDAQ: ZG)(NASDAQ: Z) surprised the market by exiting the iBuying business recently. With only four major players in the space (now three), what does it mean for the pure-play iBuyers

Over the past year, Shiba Inu (CRYPTO: SHIB) has skyrocketed 68,000,000%, growing at a pace that could turn relatively small sums of money into millions of dollars. While impressive, Shiba Inu lacks

Investors sure love their dividends, but often, buying a high-dividend stock means buying companies when their prices are low. Low prices could be a sign of risk, but they could also present an

Nvidia's (NASDAQ: NVDA) stock price has stretched to a high valuation of 115 times earnings following another blockbuster earnings report. That is an expensive price tag, but Nvidia is keeping it

When it comes to space investing, SpaceX gets all the headlines.

SpaceX proved the concept of reusable rockets to send satellites to orbit. SpaceX won the lunar lander contract. And SpaceX is the

Inovio Pharmaceuticals (NASDAQ: INO) and Ocugen (NASDAQ: OCGN) are two small biotechs that hope to win regulatory authorizations for COVID-19 vaccines in the not-too-distant future. In this Motley

This is arguably the most difficult time to be an income investor in decades. For one, the S&P 500 is yielding less than 1.3%, which is very close to its all-time low of 1.1% set back in 2000. Along

If you want your Social Security checks to be as large as possible, you'll need to put off claiming them until you've reached age 70. Retirees earn delayed retirement credits that raise their

The Canadian cannabis company Tilray (NASDAQ: TLRY) hasn't been the best performer over the last six months, with its shares falling by more than 31% while the larger market rose by 14%. Of course